Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 23, 2003, Pages 4217-4221

  Schneider, Peter ^a   Hawser, Stephen ^a   Islam, Khalid ^a  

^a Arpida Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE INHIBITOR; ICLAPRIM; PYRIMIDINE DERIVATIVE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DRUG DESIGN; DRUG SELECTIVITY; DRUG SYNTHESIS; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RESPIRATORY TRACT INFECTION;

POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0242569143     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.07.023     Document Type: Article

References (39)

1. Woods D.D. Brit. J. Exptl. Path. 21:1940;74.
2. Hitchings G.H. Angewandte Chemie. 101:1989;903.
3. Hitchings G.H. Drug Intell. Clin. Pharm. 16:1982;843.
4. Hitchings G.H., Burchall J.J. Adv. Enzymol. 27:1965;417.
5. Hitchings G.H., Smith S.L. Adv. Enzyme Reg. 18:1980;349.
6. Hitchings, G. H.; Roth, R. In Enzyme Inhibitors as Drugs; Sandler, M., Ed.; University Park: Baltimore, 1980; p 263.
7. Then R.L. J. Chemother. (Florence, Italy). 5:1993;361.
8. Veyssier, P. In Antibiotiques, Agents Antibactériens et Antifongigues; Bryskier, A., Ed; Ellipses: Paris, 1999; p 995.
9. Chang A.C.Y., Nunberg J.H., Kaufman R.J., Ehrlich H.A., Schimke R.T., Cohen S.N. Nature. 275:1978;617.
10. Rabasseda X., Mealy N. Drugs Today. 30:1994;381.
11. Birdsall B., Feeney J., Pascual C., Roberts G.C.K., Kompis I., Then R.L., Mueller K., Kroehn A. J. Med. Chem. 27:1984;1672.
12. Morgan W.D., Birdsall B., Polshakov V.I., Sali D., Kompis I., Feeney J. Biochemistry. 34:1995;11690.
13. Kuyper L.F., Roth B., Baccanari D.P., Ferone R., Bedell C.R., Champness J.N., Dann J.G., Norrington F.E., Baker D.J. J. Med. Chem. 28:1985;303.
14. Pan R., Bowen D., Southerland W.M. Biopharm. Drug Dispos. 20:1999;335.
15. Li R.L., Dietrich S.W., Hansch C. J. Med. Chem. 24:1981;538.
16. Selassie C.D., Li R.L., Poe M., Hansch C. J. Med. Chem. 34:1991;46.
17. Baccanari D.P., Kuyper L.F. J. Chemother. (Florence, Italy). 5:1993;393.
18. Dale G.E., Broger C., D'Arcy A., Hartmann P.G., DeHoogt R., Jolidon S., Kompis I., Labhardt A.M., Langen H., Locher H., Page M.G.P., Stueber D., Then R.L., Wipf B., Oefner C. J. Mol. Biol. 266:1997;23.
19. Rouch D.A., Messerotti L.J., Loo L.S.L., Jackson C.A., Skurray R.A. Mol. Microbiol. 3:1989;161.
20. Burdeska A., Ott M., Bannwarth W., Then R.L. FEBS Lett. 266:1990;159.
21. Liebenow, W.; Prikryl, J. US Patent 3,992,379, 1974; J. Antimicrob. Chemother. 1979, 5, 1.
22. Salmi H.A., Lehtomaki K., Kylmamaa T. Drugs Exptl. Clin. Res. 12:1986;349.
23. Debnath A.K. J. Med. Chem. 45:2002;41.
24. Graffner-Nordberg M., Kolmodin K., Åqvist J., Queener S.F., Hallberg A. J. Med. Chem. 44:2001;2391.
25. Chan D.C., Laughton C.A., Queener S.F., Stevens M.F.G. J. Med. Chem. 44:2001;2555.
26. Masciadri, R. US Patent 5,773,446, 1995. Chem Abstr. 1997, 127, 108943.
27. Wipf P., Weiner W. J. Org. Chem. 64:1999;5321.
28. Hartmann, P. G.; Kompis, I.; Jaeger, J.; Mukhija, S.; Islam, K. Abstracts, F2020, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.
29. Gemmel, C. G.; Middlesmas, G. Abstracts, F2022, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.
30. Good, C. E.; Windau, A.; Bajaksouzian, S.; Jacobs, M. R.; Appelbaum, P. C. Abstracts, F2023, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.
31. Bajaksouzian, S.; Windau, A.; Appelbaum, P. C.; Jacobs, M. R. Abstracts, F2024, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.
32. S.; Windau, A.; Bajaksouzian, S.; Appelbaum, P. C.; Jacobs, M. R. Abstracts, F2025, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.
33. Hawser, S.; Weiss, L.; Fischer, M.; Gillessen, D.; Kompis, I.; Islam, K. Abstracts, F2019, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.
34. Then, R. L.; Hartman, P. G.; Locher, H. H. Abstracts, F2021, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.
35. Jacobs, M. R.; Windau, A.; Bajaksouzian, S.; Appelbaum, P. C. Abstracts, F2026, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.
36. Hawser, S.; Weiss, L.; Fischer, M.; Jaeger, J.; Greiveldinger, S. Abstracts, F2029, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.
37. Hawser, S.; Haldimann, A.; Parisi, S.; Gillessen, D.; Islam, K. Abstracts, F2028, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.
38. Preoptimization with Mechanics (MM3), followed by an optimized geometry calculation in MOPAC using PM5 parameters. Program CAChe® 5.0 from Fujitsu Limited.
39. Candiani, G. P.; Romano, G.; Jabes, D.; Islam, K. Abstracts, F2030, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Sept. 27-30, 2002; American Society for Microbiology: Washington, DC, 2002.